Explore current research projects in the Schizophrenia Program or search our open clinical trials and medical research studies.
The Schizophrenia Program is involved in a wide range of genetic research projects in collaboration with genetic laboratories at Harvard Medical School and other institutions.
The Schizophrenia Program Neuroimaging Investigators use MRI and other imaging technologies to conduct cutting-edge research on the neurobiological basis of schizophrenia.
The Psychopharmacology Lab research team seeks better medication options to treat schizophrenia symptoms and mitigate the medical problems associated with existing medications.
At the Mass General Smoking Cessation Program, people with schizophrenia receive the best in personally tailored behavioral and medication treatment for smoking cessation as well as prevention of relapse to smoking.
At the Weight Loss and Diabetes Prevention Program, people with schizophrenia receive state-of-the-art intervention for weight loss, diabetes prevention, cardiovascular fitness, and improved overall health.
There are no results found in this category.
Use the search box in the upper right corner of the page to find related content.